期刊文献+

运动神经元病165例临床特征及危险因素分析

Clinical features and related risk factors of motor neuron disease : an analysis of 165 cases
原文传递
导出
摘要 目的探讨运动神经元病(MND)的临床特征及相关危险因素,为临床治疗提供依据。方法回顾性分析165例MND患者的临床资料,包括一般资料、首发症状部位、神经系统体征、影像学检查、伴随疾病、误诊情况、治疗情况、职业分布等。结果165例MND患者中,男女比例为1.84:1,平均发病年龄(52.2±10.4)岁;单侧上肢起病66例(40.0%),单侧下肢起病46例(27.9%),双上肢起病5例(3.0%),双下肢起病3例(1.8%),四肢起病12例(7.3%),延髓起病33例(20.0%);70例患者曾被误诊,误诊率为42.4%;发病患者中,农林工作者76例(46.1%),有毒物质、金属、煤炭等接触者48例(29.1%),吸烟者51例(30.9%);多数给予口服维生素B1、维生素B12等营养神经治疗,未见明显疗效。结论MND患者多以单侧肢体远端肌无力或肌萎缩起病,逐渐累及四肢。发病高峰集中在50~59岁,男性发病率高于女性;误诊率高;尚无有效治疗手段;职业暴露、手术外伤、毒物/药物接触史、吸烟等可能是MND的危险因素。 Objective To investigate the clinical characteristics and related risk factors of motor neuron disease (MND). Methods The clinical data of 165 MND patients including general information, initial symptom, signs of nervous system, imaging examination, concominant diseases, misdiagnosis condition, therapies and professional distribution were analyzed retrospectively. Results In 165 MND patients, the ratio of male to female was 1.84: 1, and the average onset age was (52.2 ± 10.4) years. The onset sites of the disease accounted for 40.0% in unilateral upper limb, 27.9% in unilateral lower limb, 3.0% in bilateral upper extremities, 1.8% in bilateral lower extremities, 7.3% in four limbs, 20.0% in medullary bulb, respectively. Of 165 MND patients, 70 were ever misdiagnosed with a misdiagnosis rate of 42.4%. Of 165 MND patients, 76 (46.1% ) were agriculture and forestry workers, 48 (29.1%) were exposured to toxic substances or metal material, 51 (30.9%) were smoker. Most pa- tients were administered by oral vitamin Bl, vitamin B12 and other neurotrophic drugs, but no apparent effect was found. Conclusions In most MND patients, the MND is characterized by the onset of weakness and atrophy from unilateral distal limb, and then the four limbs are gradually affected. The onset peak is concentrated in the ages of 50 to 59 years. The prevalence of male is higher than that of female. The misdiagnosis rate is higher. MND is still lack of effective treatment. The risk factors of MND may be associated with oceupational exposures, surgical trauma, poison/drug contact history and smoking.
出处 《中国临床研究》 CAS 2014年第3期266-268,共3页 Chinese Journal of Clinical Research
基金 山西省自然科学基金项目(2013011057-2) 2011年山西省高校院基金项目(09019#)
关键词 运动神经元病 临床特征 危险因素 误诊 Motor neuron disease Clinical feature Risk factor Misdiagnosis
  • 相关文献

参考文献13

  • 1Logroscino G, Traynor B J, Hardiman O, et al. Descriptive epidemiol- ogy of amyotrophic lateral sclerosis : new evidence and unsolved is- sues[ J]. J Neurol Neurosurg Psychiatry ,2008,79 ( 1 ) :6 - 11.
  • 2Kraemer M, Buerger M, Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis[ J]. Clin Neurol Neurosur, 2010,112(2) :103 - 105.
  • 3Abrahams S, Goldstein LH, Simmons A, et al. Word retrieval in amyotrophic lateral sclerosis:a functional magnetic resonance ima- ging study [ J ]. Brain,2004,127 (7) : 1507 - 1517.
  • 4刘明生,崔丽英,汤晓芙,李本红,杜华.运动神经元病162例的节段性运动神经传导测定分析[J].中华神经科杂志,2005,38(11):694-696. 被引量:13
  • 5杨娟,张成,任惠.肌萎缩侧索硬化症患者脑脊液和血液中的生物学标记研究进展[J].国际神经病学神经外科学杂志,2009,36(5):433-436. 被引量:5
  • 6王惠芳,樊东升,张俊,张华纲,王晓飞,鲁明,康德宣.肌萎缩侧索硬化症的院前误诊分析[J].中国现代神经疾病杂志,2005,5(4):240-243. 被引量:13
  • 7汤晓芙,潘华,李本红,杜华.胸段脊旁肌肌电图在肌萎缩侧索硬化诊断中的作用[J].中华神经科杂志,2003,36(3):176-178. 被引量:30
  • 8Huisman MH, Seelen M, de Jong SW, et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis [ J ]. J Neurol Neurosurg Psychiatry ,2013,84 (9) :976 - 981.
  • 9Beghi E, Logroscino G, Chib A, et al. Amyotrophic lateral sclerosis, physical exercise, trauma and sports : results of a population-based pi- lot case-control study [ J ]. Amyotroph Lateral Scler, 2010,11 ( 3 ) : 289 - 292.
  • 10Caller TA, Chipman JW, Field NC, et al. Spatial analysis of amyotro- phic lateral sclerosis in Northern New England, USA, 1997 -2009 [J]. Muscle Nerve,2013,48(2):235 -241.

二级参考文献42

  • 1康德瑄,樊东升.胸锁乳突肌肌电图在鉴别肌萎缩侧索硬化与颈椎病性脊髓病的研究[J].中国神经精神疾病杂志,1994,20(1):5-7. 被引量:47
  • 2Arthur J, Wayne A, Victor G, et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther, 2001, 69(3) : 89-95.
  • 3Mitchell RM, Freeman WM, Randazzo WT, et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology, 2009, 72( 1 ) : 14-19.
  • 4Grundstrom E, Lindholm D, Johansson A, et al. GDNF but not BDNF is increased in eerebrospinal fluid in amyotrophie lateral sclerosis. Neuroreport, 2000, 11 ( 8 ) : 1781- 1783.
  • 5Nagata T, Nagano I, Shiote M, et al. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol Res, 2007, 29 ( 8 ) : 772 -776.
  • 6Moreau C, Devos D, Brunaud-Danel V, et al. Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS. J Neurol Neurosurg Psychiatry, 2006, 77 (2) : 255 -257.
  • 7Brettschneider J, Widl K, Schattauer D, et al. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosei Lett, 2007, 416(3 ) : 257-260.
  • 8Camu W, Billiard M, Balady-Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand, 1993, 88(1) : 51- 55.
  • 9Plaitakis A, Constantakakis E. Altered metabolism of excitatory amino acids, N - acetyl - aspartate and N - acetyl - Glutamate in amyotrophic lateral sclerosis. Brain Res Bull, 1993, 30 (3-4) : 381-386.
  • 10Vastag B. Stem cells step closer to the clinic: paralysis partially reversed in rats with ALS-like disease. JAMA, 2001, 285(13): 1691.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部